48 results
8-K
EX-2.1
NBRVF
Nabriva Therapeutics plc
31 Jul 23
Entry into a Material Definitive Agreement
8:07am
pursuant to Section 1.3.1(c);
(d) any Liability pursuant to any Environmental Law arising from or related to any action, event, circumstance … , relating to any Environmental Laws that would reasonably be expected to result in a liability to Purchaser as a result of the consummation
8-K
EX-10.1
z1izvomz
27 Sep 21
Entry into a Material Definitive Agreement
8:57am
8-K
EX-10.1
o7bpfzf sca
1 Mar 21
Nabriva Therapeutics Announces $25.4 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
5:28pm
8-K
EX-10.1
t11qo7gcfl59zrc9
12 Feb 21
Entry into a Material Definitive Agreement
5:01pm
8-K
EX-10.1
epldlkh
14 Dec 20
Nabriva Therapeutics Announces Proposed Public Offering
4:25pm
8-K
EX-10.1
13hpgd3htvvrl75m7
1 Jun 20
Nabriva Therapeutics Announces $38 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
6:28am